Vanessa Rivera-Amill to Dengue
This is a "connection" page, showing publications Vanessa Rivera-Amill has written about Dengue.
Connection Strength
3.667
-
Flores-P?rez PN, Collazo-Llera JA, Rodr?guez-Alvarado FA, Rivera-Amill V. The Emerging Role of Circulating T Follicular Helper Cells in Dengue Virus Immunity: Balancing Protection and Pathogenesis. Viruses. 2025 04 30; 17(5).
Score: 0.827
-
Paz-Bailey G, S?nchez-Gonz?lez L, Torres-Velasquez B, Jones ES, Perez-Padilla J, Sharp TM, Lorenzi O, Delorey M, Munoz-Jordan JL, Tomashek KM, Waterman SH, Alvarado LI, Rivera-Amill V. Predominance of Severe Plasma Leakage in Pediatric Patients With Severe Dengue in Puerto Rico. J Infect Dis. 2022 11 28; 226(11):1949-1958.
Score: 0.700
-
Madewell ZJ, Rodriguez DM, Thayer MB, Rivera-Amill V, Aponte JT, Marzan-Rodriguez M, Paz-Bailey G, Adams LE, Wong JM. Machine Learning for Improved Dengue Diagnosis in Puerto Rico. Trop Med Int Health. 2025 Dec; 30(12):1283-1294.
Score: 0.212
-
Camprub?-Ferrer D, Torres-Vel?squez B, Perez Padilla J, Wong J, S?nchez-Gonz?lez L, Munoz-Jordan JL, Rodriguez Vargas DM, Rivera-Amill V, Adams LE, Paz-Bailey G. Severity of Primary and Secondary Dengue Virus 1 Infections: A Hospital-Based Study in Puerto Rico, 2012-2014. Am J Trop Med Hyg. 2025 Aug 06; 113(2):361-365.
Score: 0.208
-
Madewell ZJ, Rodriguez DM, Thayer MB, Rivera-Amill V, Paz-Bailey G, Adams LE, Wong JM. Machine learning for predicting severe dengue in Puerto Rico. Infect Dis Poverty. 2025 Feb 04; 14(1):5.
Score: 0.204
-
Rodriguez DM, Madewell ZJ, Torres JM, Rivera A, Wong JM, Santiago GA, Rivera-Amill V, Paz-Bailey G, Marzan-Rodriguez M, Adams LE. Epidemiology of Dengue - Puerto Rico, 2010-2024. MMWR Morb Mortal Wkly Rep. 2024 Dec 12; 73(49):1112-1117.
Score: 0.201
-
Medina FA, Vila F, Adams LE, Cardona J, Carrion J, Lamirande E, Acosta LN, De Le?n-Rodr?guez CM, Beltran M, Grau D, Rivera-Amill V, Balmaseda A, Harris E, Madewell ZJ, Waterman SH, Paz-Bailey G, Whitehead S, Mu?oz-Jord?n JL. Comparison of the sensitivity and specificity of commercial anti-dengue virus IgG tests to identify persons eligible for dengue vaccination. J Clin Microbiol. 2024 Oct 16; 62(10):e0059324.
Score: 0.197
-
Madewell ZJ, Hernandez-Romieu AC, Wong JM, Zambrano LD, Volkman HR, Perez-Padilla J, Rodriguez DM, Lorenzi O, Espinet C, Munoz-Jordan J, Frasqueri-Quintana VM, Rivera-Amill V, Alvarado-Domenech LI, Sainz D, Bertran J, Paz-Bailey G, Adams LE. Sentinel Enhanced Dengue Surveillance System - Puerto Rico, 2012-2022. MMWR Surveill Summ. 2024 05 30; 73(3):1-29.
Score: 0.194
-
Adams LE, Hitchings MDT, Medina FA, Rodriguez DM, S?nchez-Gonz?lez L, Moore H, Whitehead SS, Mu?oz-Jord?n JL, Rivera-Amill V, Paz-Bailey G. Previous Dengue Infection among Children in Puerto Rico and Implications for Dengue Vaccine Implementation. Am J Trop Med Hyg. 2023 08 02; 109(2):413-419.
Score: 0.182
-
Rodriguez DM, Major CG, S?nchez-Gonz?lez L, Jones E, Delorey MJ, Alonso C, Rivera-Amill V, Paz-Bailey G, Adams LE. Dengue vaccine acceptability before and after the availability of COVID-19 vaccines in Puerto Rico. Vaccine. 2023 06 01; 41(24):3627-3635.
Score: 0.180
-
Wong JM, Volkman HR, Adams LE, Oliveras Garc?a C, Martinez-Qui?ones A, Perez-Padilla J, Bertr?n-Pasarell J, Sainz de la Pe?a D, Tosado-Acevedo R, Santiago GA, Mu?oz-Jord?n JL, Torres-Vel?squez BC, Lorenzi O, S?nchez-Gonz?lez L, Rivera-Amill V, Paz-Bailey G. Clinical Features of COVID-19, Dengue, and Influenza among Adults Presenting to Emergency Departments and Urgent Care Clinics-Puerto Rico, 2012-2021. Am J Trop Med Hyg. 2023 01 11; 108(1):107-114.
Score: 0.175
-
Medina FA, Vila F, Premkumar L, Lorenzi O, Paz-Bailey G, Alvarado LI, Rivera-Amill V, de Silva A, Waterman S, Mu?oz-Jord?n J. Capacity of a Multiplex IgM Antibody Capture ELISA to Differentiate Zika and Dengue Virus Infections in Areas of Concurrent Endemic Transmission. Am J Trop Med Hyg. 2021 12 20; 106(2):585-592.
Score: 0.164
-
Alvarado LI, Lorenzi OD, Torres-Vel?squez BC, Sharp TM, Vargas L, Mu?oz-Jord?n JL, Hunsperger EA, P?rez-Padilla J, Rivera A, Gonz?lez-Zeno GE, Galloway RL, Glass Elrod M, Mathis DL, Oberste MS, Nix WA, Henderson E, McQuiston J, Singleton J, Kato C, Garc?a-Gubern C, Santiago-Rivera W, Muns-Sosa R, Ortiz-Rivera JD, Jim?nez G, Rivera-Amill V, And?jar-P?rez DA, Horiuchi K, Tomashek KM. Distinguishing patients with laboratory-confirmed chikungunya from dengue and other acute febrile illnesses, Puerto Rico, 2012-2015. PLoS Negl Trop Dis. 2019 07; 13(7):e0007562.
Score: 0.139
-
Adams LE, S?nchez-Gonz?lez L, Rodriguez DM, Ryff K, Major C, Lorenzi O, Delorey M, Medina FA, Mu?oz-Jord?n JL, Brown G, Ortiz M, Waterman SH, Rivera-Amill V, Paz-Bailey G. Risk factors for infection with chikungunya and Zika viruses in southern Puerto Rico: A community-based cross-sectional seroprevalence survey. PLoS Negl Trop Dis. 2022 06; 16(6):e0010416.
Score: 0.042
-
Munoz-Jordan J, Cardona J, Beltr?n M, Col?n C, Schiffer J, Stewart-Clark E, Zellner B, Semenova V, Li Y, Jia LT, Maniatis P, Pawloski L, Adams L, Paz-Bailey G, Rivera-Amill V, Medina F. Evaluation of Serologic Cross-Reactivity Between Dengue Virus and SARS-CoV-2 in Patients with Acute Febrile Illness - United States and Puerto Rico, April 2020-March 2021. MMWR Morb Mortal Wkly Rep. 2022 Mar 11; 71(10):375-377.
Score: 0.042